ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 174 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $10,477,000 | +7.9% | 373,500 | 0.0% | 0.03% | +8.3% |
Q4 2020 | $9,711,000 | -21.7% | 373,500 | +12.0% | 0.02% | -36.8% |
Q3 2020 | $12,396,000 | -16.3% | 333,500 | +15.6% | 0.04% | -29.6% |
Q2 2020 | $14,803,000 | +149.1% | 288,500 | +53.1% | 0.05% | +86.2% |
Q1 2020 | $5,943,000 | -47.1% | 188,500 | 0.0% | 0.03% | -32.6% |
Q4 2019 | $11,240,000 | +62.7% | 188,500 | 0.0% | 0.04% | +53.6% |
Q3 2019 | $6,910,000 | -21.2% | 188,500 | 0.0% | 0.03% | -20.0% |
Q2 2019 | $8,769,000 | +19.0% | 188,500 | +2.7% | 0.04% | +12.9% |
Q1 2019 | $7,368,000 | +60.2% | 183,500 | +83.5% | 0.03% | +34.8% |
Q4 2018 | $4,600,000 | +3.7% | 100,000 | 0.0% | 0.02% | +27.8% |
Q3 2018 | $4,437,000 | +612.2% | 100,000 | +528.9% | 0.02% | +500.0% |
Q2 2018 | $623,000 | -65.4% | 15,900 | -36.1% | 0.00% | -62.5% |
Q1 2018 | $1,801,000 | +112.1% | 24,900 | +93.0% | 0.01% | +100.0% |
Q4 2017 | $849,000 | +212.1% | 12,900 | +5.7% | 0.00% | +300.0% |
Q4 2015 | $272,000 | -5.6% | 12,200 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $288,000 | -71.1% | 12,200 | 0.0% | 0.00% | -75.0% |
Q2 2015 | $997,000 | -56.1% | 12,200 | -50.2% | 0.00% | -55.6% |
Q1 2015 | $2,269,000 | +59.5% | 24,500 | -30.4% | 0.01% | +50.0% |
Q4 2014 | $1,423,000 | +142.4% | 35,200 | +46.7% | 0.01% | +200.0% |
Q3 2014 | $587,000 | – | 24,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |